Aortic valve replacement for aortic stenosis in patients under 65-years-old

IF 18 Q4 Medicine
R. Coelho, T. Bourguignon, A. Bernard
{"title":"Aortic valve replacement for aortic stenosis in patients under 65-years-old","authors":"R. Coelho,&nbsp;T. Bourguignon,&nbsp;A. Bernard","doi":"10.1016/j.acvdsp.2023.04.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p><span><span>Aortic valve stenosis is the most common valve disease in the world, with particularly poor prognosis if left untreated. Its management in young patients is based on surgical </span>aortic valve<span> replacement (bioprosthesis or mechanical prosthesis, and Ross or Ozaki technique), and rarely percutaneous (TAVR). In this population, the choice of the technique used is of primary importance in terms of hemodynamic<span> performance and durability. The objective of this work is to compare 5 different techniques used in the management of aortic stenosis </span></span></span>in patients under 65 years old at CHRU of Tours.</p></div><div><h3>Method</h3><p>We conducted a retrospective, single-center, observational study at the CHRU of Tours. Five cohorts (mechanical prosthesis, INSPIRIS bioprosthesis, Ross, Ozaki and TAVR) were compared in terms of pre-, per- and postoperative, clinical and hemodynamic parameters.</p></div><div><h3>Results</h3><p><span>We included 163 patients under 65-years-old with aortic stenosis operated at the CHRU of Tours between January 2015 and October 2021. Hemodynamically, after stratification on the prosthetic caliber, the best results were found with the Ozaki and Ross techniques, followed by TAVR, the INSPIRIS bioprosthesis and finally the mechanical prosthesis. A severe prosthesis-patient mismatch rate of 10% was found in all patients, with no significant difference between the different techniques (</span><em>P</em> <!-->=<!--> <!-->0.1827). Clinically, there was no significant difference between the groups in terms of mortality or re-intervention related to the aortic valve after a mean follow-up of 19.2 months (<em>P</em> <!-->=<!--> <span>0.6545). However, pacemaker implantation was significantly higher in the TAVR group (</span><em>P</em> <!-->=<!--> <!-->0.0178).</p></div><div><h3>Conclusion</h3><p>Each surgical and percutaneous technique has its specific advantages and complications. The excellent short-term hemodynamic parameters of the Ross and Ozaki techniques seem to encourage the use of these techniques in the management of aortic stenosis in young patients. More powerful studies with a longer follow-up time would allow to confirm these preliminary results.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 3","pages":"Page 245"},"PeriodicalIF":18.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878648023001453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Aortic valve stenosis is the most common valve disease in the world, with particularly poor prognosis if left untreated. Its management in young patients is based on surgical aortic valve replacement (bioprosthesis or mechanical prosthesis, and Ross or Ozaki technique), and rarely percutaneous (TAVR). In this population, the choice of the technique used is of primary importance in terms of hemodynamic performance and durability. The objective of this work is to compare 5 different techniques used in the management of aortic stenosis in patients under 65 years old at CHRU of Tours.

Method

We conducted a retrospective, single-center, observational study at the CHRU of Tours. Five cohorts (mechanical prosthesis, INSPIRIS bioprosthesis, Ross, Ozaki and TAVR) were compared in terms of pre-, per- and postoperative, clinical and hemodynamic parameters.

Results

We included 163 patients under 65-years-old with aortic stenosis operated at the CHRU of Tours between January 2015 and October 2021. Hemodynamically, after stratification on the prosthetic caliber, the best results were found with the Ozaki and Ross techniques, followed by TAVR, the INSPIRIS bioprosthesis and finally the mechanical prosthesis. A severe prosthesis-patient mismatch rate of 10% was found in all patients, with no significant difference between the different techniques (P = 0.1827). Clinically, there was no significant difference between the groups in terms of mortality or re-intervention related to the aortic valve after a mean follow-up of 19.2 months (P = 0.6545). However, pacemaker implantation was significantly higher in the TAVR group (P = 0.0178).

Conclusion

Each surgical and percutaneous technique has its specific advantages and complications. The excellent short-term hemodynamic parameters of the Ross and Ozaki techniques seem to encourage the use of these techniques in the management of aortic stenosis in young patients. More powerful studies with a longer follow-up time would allow to confirm these preliminary results.

65岁以下患者主动脉瓣狭窄的主动脉瓣置换术
主动脉瓣狭窄是世界上最常见的瓣膜疾病,如果不及时治疗,预后特别差。年轻患者的治疗基于外科主动脉瓣置换术(生物假体或机械假体,Ross或Ozaki技术),很少经皮(TAVR)。在这一人群中,就血流动力学性能和耐久性而言,所使用的技术的选择是最重要的。本研究的目的是比较图尔CHRU治疗65岁以下患者主动脉瓣狭窄的5种不同技术。方法在图尔斯CHRU进行回顾性、单中心观察性研究。五个队列(机械假体、INSPIRIS生物假体、Ross、Ozaki和TAVR)在术前、术后、临床和血流动力学参数方面进行比较。我们纳入了163例2015年1月至2021年10月在图尔斯CHRU手术的65岁以下主动脉瓣狭窄患者。血液动力学方面,在假体口径分层后,Ozaki和Ross技术的效果最好,其次是TAVR、INSPIRIS生物假体,最后是机械假体。所有患者假体与患者的严重失配率均为10%,不同技术间无显著差异(P = 0.1827)。临床方面,平均随访19.2个月后,两组患者的死亡率和与主动脉瓣相关的再干预均无显著差异(P = 0.6545)。而TAVR组起搏器植入率明显高于TAVR组(P = 0.0178)。结论每一种手术和经皮穿刺技术都有其独特的优点和并发症。Ross和Ozaki技术出色的短期血流动力学参数似乎鼓励了这些技术在年轻患者主动脉狭窄治疗中的应用。更有力的研究和更长的随访时间将允许证实这些初步结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archives of Cardiovascular Diseases Supplements
Archives of Cardiovascular Diseases Supplements CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
508
期刊介绍: Archives of Cardiovascular Diseases Supplements is the official journal of the French Society of Cardiology. The journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles, editorials, and Images in cardiovascular medicine. The topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Additionally, Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信